API
| Our API portfolio** consists of the following: |
| Therapeutic Category |
Name of API |
Regulatory Status |
| USDMF |
EDMF |
COS |
| Anti-cancer |
Anastrazole (USP) |
√ |
√ |
|
| |
Bicalutamide (USP) |
√ |
√ |
# |
| Busulfan (USP) |
* |
|
* |
| Carboplatin (USP/EP) |
* |
|
√ |
| Decitabine |
* |
# |
|
| Docetaxel Trihydrate (EP) |
|
|
* |
| Docetaxel anhydrous |
* |
* |
# |
| Gemcitabine HCl (USP) |
√ |
|
√ |
| Irinotecan HCl (USP) |
√ |
√ |
|
| Letrozole (USP/EP) |
√ |
|
√ |
| Oxaliplatin (USP/EP) |
√ |
|
√ |
| Paclitaxel (USP/EP) |
√ |
|
√ |
| Temsirolimus |
# |
# |
|
| Topotecan HCl |
√ |
√ |
|
| Bendamustine |
# |
# |
|
| Imatinib Mesylate |
# |
# |
|
| Anaesthetics |
Bupivacaine (USP/EP) |
# |
|
# |
| |
Levobupivacaine |
# |
# |
|
| Ropivacaine (USP/EP) |
# |
|
# |
| Expectorant |
Ambroxol HCl (BP/EP) |
|
|
* |
| Vasodilator |
Buflomedil HCl (EP) |
|
|
* |
| Muscle Relaxant |
Metaxalone |
√ |
|
|
| Drug Intermediate |
10-DAB |
|
|
|
|
√Granted *Filed #Under preparation
**None of the above products will be supplied to countries in which these could be in conflict with the existing patents. The final responsibility lies exclusively with the buyer.
Print this page
Send link to a friend